View ValuationZhejiang Runtu 향후 성장Future 기준 점검 1/6Zhejiang Runtu은 연간 수입과 매출이 각각 7.3%와 9.1% 증가할 것으로 예상되고 EPS는 연간 5.2%만큼 증가할 것으로 예상됩니다.핵심 정보7.3%이익 성장률5.21%EPS 성장률Chemicals 이익 성장29.9%매출 성장률9.1%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트29 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Jian Wo was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.공시 • Apr 29Zhejiang Runtu Co., Ltd., Annual General Meeting, May 29, 2026Zhejiang Runtu Co., Ltd., Annual General Meeting, May 29, 2026, at 14:00 China Standard Time. Location: Building 1, No. 1009, Shimin Avenue, Shangyu District, Shaoxing, Zhejiang China공시 • Mar 31Zhejiang Runtu Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026공시 • Dec 31Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026공시 • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025공시 • Jul 02Zhejiang Runtu Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025공시 • May 27Zhejiang Runtu Co., Ltd. Approves Dividend for 2024Zhejiang Runtu Co., Ltd. at its AGM held on May 23, 2025 approved Cash dividend/10 shares (tax included): CNY 1.50000000 for 2024.공시 • Apr 29Zhejiang Runtu Co., Ltd., Annual General Meeting, May 23, 2025Zhejiang Runtu Co., Ltd., Annual General Meeting, May 23, 2025, at 14:00 China Standard Time.공시 • Mar 31Zhejiang Runtu Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025공시 • Dec 31Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.035 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.04 (up from CN¥0.035 loss in 3Q 2023). Revenue: CN¥1.38b (up 6.8% from 3Q 2023). Net income: CN¥46.4m (up CN¥88.0m from 3Q 2023). Profit margin: 3.4% (up from net loss in 3Q 2023). Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.공시 • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Reported Earnings • Aug 31Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: CN¥1.44b (down 8.6% from 2Q 2023). Net income: CN¥103.3m (down 23% from 2Q 2023). Profit margin: 7.2% (down from 8.6% in 2Q 2023). Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance.공시 • Jun 29Zhejiang Runtu Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Zhejiang Runtu Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024Declared Dividend • Jun 21Dividend reduced to CN¥0.15Dividend of CN¥0.15 is 40% lower than last year. Ex-date: 26th June 2024 Payment date: 26th June 2024 Dividend yield will be 2.7%, which is about the same as the industry average. Sustainability & Growth Dividend is not covered by earnings (445% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 1.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 395% to bring the payout ratio under control. EPS is expected to grow by 76% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio.공시 • Jun 20Zhejiang Runtu Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 26 June 2024Zhejiang Runtu Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.50000000 on A shares for the year 2023. Record date is 25 June 2024. Ex-date is 26 June 2024. Payment date is 26 June 2024.공시 • May 02Zhejiang Runtu Co., Ltd. Proposes Final Cash Dividend for the Year 2023Zhejiang Runtu Co., Ltd. proposed final cash dividend of CNY 1.50000000 per ten shares (tax included) for the year 2023.공시 • May 01Zhejiang Runtu Co., Ltd., Annual General Meeting, May 24, 2024Zhejiang Runtu Co., Ltd., Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: Building 1, No. 1009, Shimin Avenue, Shangyu District, Shaoxing, Zhejiang ChinaReported Earnings • Apr 30First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: CN¥1.25b (down 6.9% from 1Q 2023). Net income: CN¥1.31m (down 86% from 1Q 2023). Profit margin: 0.1% (down from 0.7% in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.공시 • Mar 30Zhejiang Runtu Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥5.90, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 43% over the past three years.공시 • Dec 30Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.035 loss per share (vs CN¥0.046 profit in 3Q 2022)Third quarter 2023 results: CN¥0.035 loss per share (down from CN¥0.046 profit in 3Q 2022). Revenue: CN¥1.30b (down 10% from 3Q 2022). Net loss: CN¥41.6m (down 182% from profit in 3Q 2022). Revenue is forecast to grow 7.9% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.공시 • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023New Risk • Sep 13New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 45% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 111% Paying a dividend despite having no free cash flows. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.3% net profit margin).Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.25 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥1.57b (down 14% from 2Q 2022). Net income: CN¥134.5m (down 53% from 2Q 2022). Profit margin: 8.6% (down from 16% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.공시 • Jun 14Zhejiang Runtu Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 20 June 2023Zhejiang Runtu Co., Ltd. announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.50000000 for the year 2022, payable on 20 June 2023. Record date is 19 June 2023. Ex-date is 20 June 2023.공시 • Jun 01Zhejiang Runtu Co., Ltd. Approves Dividend for 2022Zhejiang Runtu Co., Ltd. announced at the AGM held on May 26, 2023 that the company approved Cash dividend/10 shares (tax included) of CNY2.50000000 for 2022.공시 • May 06+ 1 more updateZhejiang Runtu Co., Ltd., Annual General Meeting, May 26, 2023Zhejiang Runtu Co., Ltd., Annual General Meeting, May 26, 2023, at 14:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider 2022 annual report and its summary; to consider 2022 profit distribution plan; to consider Confirmation of 2022 remuneration for directors and supervisors; to consider Reappointment of 2023 audit firm; to consider Provision of guarantee quota for subsidiaries and controlled sub-subsidiaries; and to consider other business matters.Reported Earnings • Apr 08Full year 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.74 in FY 2021)Full year 2022 results: EPS: CN¥0.57 (down from CN¥0.74 in FY 2021). Revenue: CN¥6.30b (up 13% from FY 2021). Net income: CN¥645.2m (down 23% from FY 2021). Profit margin: 10% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Non-Independent Director Heng Ru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.046 (vs CN¥0.24 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.046 (down from CN¥0.24 in 3Q 2021). Revenue: CN¥1.45b (down 3.3% from 3Q 2021). Net income: CN¥50.5m (down 81% from 3Q 2021). Profit margin: 3.5% (down from 18% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Reported Earnings • Sep 02Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥1.84b (up 37% from 2Q 2021). Net income: CN¥288.6m (up 29% from 2Q 2021). Profit margin: 16% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.0%, compared to a 33% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.15 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.15 in 1Q 2021). Revenue: CN¥1.58b (up 12% from 1Q 2021). Net income: CN¥211.1m (up 20% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 18%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 18% per year.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Non-Independent Director Heng Ru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CN¥0.76 (vs CN¥0.69 in FY 2020)Full year 2021 results: EPS: CN¥0.76 (up from CN¥0.69 in FY 2020). Revenue: CN¥5.60b (up 7.0% from FY 2020). Net income: CN¥863.5m (up 9.6% from FY 2020). Profit margin: 15% (in line with FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 20% per year.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.16 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.50b (up 7.7% from 3Q 2020). Net income: CN¥268.0m (up 48% from 3Q 2020). Profit margin: 18% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.13 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.34b (up 19% from 2Q 2020). Net income: CN¥224.2m (up 55% from 2Q 2020). Profit margin: 17% (up from 13% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 30Full year 2020 earnings released: EPS CN¥0.69 (vs CN¥1.19 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.23b (down 20% from FY 2019). Net income: CN¥788.2m (down 43% from FY 2019). Profit margin: 15% (down from 21% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings.Reported Earnings • Mar 12Full year 2020 earnings released: EPS CN¥0.68 (vs CN¥1.19 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.22b (down 20% from FY 2019). Net income: CN¥785.3m (down 43% from FY 2019). Profit margin: 15% (down from 21% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings.Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 9.6%. Over the next year, revenue is forecast to grow 35%, compared to a 52% growth forecast for the Chemicals industry in China.Is New 90 Day High Low • Feb 02New 90-day high: CN¥10.98The company is up 18% from its price of CN¥9.29 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.48 per share.Is New 90 Day High Low • Nov 23New 90-day high: CN¥10.38The company is up 5.0% from its price of CN¥9.87 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥16.48 per share.Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥849.2m, down 38% from the prior year. Total revenue was CN¥5.06b over the last 12 months, down 22% from the prior year.Is New 90 Day High Low • Oct 31New 90-day low: CN¥8.95The company is down 6.0% from its price of CN¥9.56 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.96 per share.이익 및 매출 성장 예측XSEC:002440 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20277,273902N/A881112/31/20267,133753N/A13613/31/20266,134805655689N/A12/31/20255,730669600645N/A9/30/20255,7872881,0391,099N/A6/30/20255,713259817883N/A3/31/20255,723260374450N/A12/31/20245,695213460548N/A9/30/20245,44895127188N/A6/30/20245,3607-337-269N/A3/31/20245,49638-193-109N/A12/31/20235,58846-248-127N/A9/30/20235,614158-482-342N/A6/30/20235,765251-271-98N/A3/31/20236,031405130316N/A1/1/20236,268607687883N/A9/30/20226,187717650902N/A6/30/20226,2379359771,243N/A3/31/20225,7368708751,156N/A1/1/20225,572836342594N/A9/30/20215,825900695793N/A6/30/20215,718814761902N/A3/31/20215,5027349851,085N/A12/31/20205,2287881,4281,548N/A9/30/20205,0598491,6781,804N/A6/30/20205,5109181,7301,835N/A3/31/20205,8551,3401,7981,995N/A12/31/20196,5131,370N/A1,840N/A9/30/20196,5211,374N/A2,010N/A6/30/20196,3221,434N/A2,017N/A3/31/20196,6711,267N/A1,462N/A12/31/20186,4641,313N/A1,226N/A9/30/20186,6131,311N/A931N/A6/30/20186,5361,239N/A818N/A3/31/20186,1991,081N/A729N/A12/31/20176,057935N/A607N/A9/30/20175,795860N/A695N/A6/30/20175,189798N/A948N/A3/31/20174,896762N/A1,114N/A12/31/20164,353660N/A1,247N/A9/30/20164,172495N/A1,901N/A6/30/20164,181398N/A1,350N/A3/31/20164,104457N/A1,390N/A12/31/20154,522734N/A1,263N/A9/30/20154,8051,079N/A509N/A6/30/20154,8701,220N/A648N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 002440 의 연간 예상 수익 증가율(7.3%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 002440 의 연간 수익(7.3%)이 CN 시장(27%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 002440 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 002440 의 수익(연간 9.1%)이 CN 시장(연간 16.3%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 002440 의 수익(연간 9.1%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 002440의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/07 09:06종가2026/06/05 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Zhejiang Runtu Co., Ltd.는 10명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xiling LiChina International Capital Corporation LimitedTao WeiGoldman SachsCheng GongGuosen Securities Co., Ltd.7명의 분석가 더 보기
Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Jian Wo was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
공시 • Apr 29Zhejiang Runtu Co., Ltd., Annual General Meeting, May 29, 2026Zhejiang Runtu Co., Ltd., Annual General Meeting, May 29, 2026, at 14:00 China Standard Time. Location: Building 1, No. 1009, Shimin Avenue, Shangyu District, Shaoxing, Zhejiang China
공시 • Mar 31Zhejiang Runtu Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
공시 • Dec 31Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026
공시 • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025
공시 • Jul 02Zhejiang Runtu Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
공시 • May 27Zhejiang Runtu Co., Ltd. Approves Dividend for 2024Zhejiang Runtu Co., Ltd. at its AGM held on May 23, 2025 approved Cash dividend/10 shares (tax included): CNY 1.50000000 for 2024.
공시 • Apr 29Zhejiang Runtu Co., Ltd., Annual General Meeting, May 23, 2025Zhejiang Runtu Co., Ltd., Annual General Meeting, May 23, 2025, at 14:00 China Standard Time.
공시 • Mar 31Zhejiang Runtu Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
공시 • Dec 31Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.035 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.04 (up from CN¥0.035 loss in 3Q 2023). Revenue: CN¥1.38b (up 6.8% from 3Q 2023). Net income: CN¥46.4m (up CN¥88.0m from 3Q 2023). Profit margin: 3.4% (up from net loss in 3Q 2023). Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.
공시 • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Reported Earnings • Aug 31Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: CN¥1.44b (down 8.6% from 2Q 2023). Net income: CN¥103.3m (down 23% from 2Q 2023). Profit margin: 7.2% (down from 8.6% in 2Q 2023). Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance.
공시 • Jun 29Zhejiang Runtu Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Zhejiang Runtu Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024
Declared Dividend • Jun 21Dividend reduced to CN¥0.15Dividend of CN¥0.15 is 40% lower than last year. Ex-date: 26th June 2024 Payment date: 26th June 2024 Dividend yield will be 2.7%, which is about the same as the industry average. Sustainability & Growth Dividend is not covered by earnings (445% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 1.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 395% to bring the payout ratio under control. EPS is expected to grow by 76% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio.
공시 • Jun 20Zhejiang Runtu Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 26 June 2024Zhejiang Runtu Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.50000000 on A shares for the year 2023. Record date is 25 June 2024. Ex-date is 26 June 2024. Payment date is 26 June 2024.
공시 • May 02Zhejiang Runtu Co., Ltd. Proposes Final Cash Dividend for the Year 2023Zhejiang Runtu Co., Ltd. proposed final cash dividend of CNY 1.50000000 per ten shares (tax included) for the year 2023.
공시 • May 01Zhejiang Runtu Co., Ltd., Annual General Meeting, May 24, 2024Zhejiang Runtu Co., Ltd., Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: Building 1, No. 1009, Shimin Avenue, Shangyu District, Shaoxing, Zhejiang China
Reported Earnings • Apr 30First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: CN¥1.25b (down 6.9% from 1Q 2023). Net income: CN¥1.31m (down 86% from 1Q 2023). Profit margin: 0.1% (down from 0.7% in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
공시 • Mar 30Zhejiang Runtu Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥5.90, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 43% over the past three years.
공시 • Dec 30Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.035 loss per share (vs CN¥0.046 profit in 3Q 2022)Third quarter 2023 results: CN¥0.035 loss per share (down from CN¥0.046 profit in 3Q 2022). Revenue: CN¥1.30b (down 10% from 3Q 2022). Net loss: CN¥41.6m (down 182% from profit in 3Q 2022). Revenue is forecast to grow 7.9% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
공시 • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023
New Risk • Sep 13New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 45% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 111% Paying a dividend despite having no free cash flows. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.3% net profit margin).
Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.25 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥1.57b (down 14% from 2Q 2022). Net income: CN¥134.5m (down 53% from 2Q 2022). Profit margin: 8.6% (down from 16% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
공시 • Jun 14Zhejiang Runtu Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 20 June 2023Zhejiang Runtu Co., Ltd. announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.50000000 for the year 2022, payable on 20 June 2023. Record date is 19 June 2023. Ex-date is 20 June 2023.
공시 • Jun 01Zhejiang Runtu Co., Ltd. Approves Dividend for 2022Zhejiang Runtu Co., Ltd. announced at the AGM held on May 26, 2023 that the company approved Cash dividend/10 shares (tax included) of CNY2.50000000 for 2022.
공시 • May 06+ 1 more updateZhejiang Runtu Co., Ltd., Annual General Meeting, May 26, 2023Zhejiang Runtu Co., Ltd., Annual General Meeting, May 26, 2023, at 14:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider 2022 annual report and its summary; to consider 2022 profit distribution plan; to consider Confirmation of 2022 remuneration for directors and supervisors; to consider Reappointment of 2023 audit firm; to consider Provision of guarantee quota for subsidiaries and controlled sub-subsidiaries; and to consider other business matters.
Reported Earnings • Apr 08Full year 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.74 in FY 2021)Full year 2022 results: EPS: CN¥0.57 (down from CN¥0.74 in FY 2021). Revenue: CN¥6.30b (up 13% from FY 2021). Net income: CN¥645.2m (down 23% from FY 2021). Profit margin: 10% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Non-Independent Director Heng Ru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.046 (vs CN¥0.24 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.046 (down from CN¥0.24 in 3Q 2021). Revenue: CN¥1.45b (down 3.3% from 3Q 2021). Net income: CN¥50.5m (down 81% from 3Q 2021). Profit margin: 3.5% (down from 18% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Reported Earnings • Sep 02Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥1.84b (up 37% from 2Q 2021). Net income: CN¥288.6m (up 29% from 2Q 2021). Profit margin: 16% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.0%, compared to a 33% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.15 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.15 in 1Q 2021). Revenue: CN¥1.58b (up 12% from 1Q 2021). Net income: CN¥211.1m (up 20% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 18%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 18% per year.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Non-Independent Director Heng Ru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CN¥0.76 (vs CN¥0.69 in FY 2020)Full year 2021 results: EPS: CN¥0.76 (up from CN¥0.69 in FY 2020). Revenue: CN¥5.60b (up 7.0% from FY 2020). Net income: CN¥863.5m (up 9.6% from FY 2020). Profit margin: 15% (in line with FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 20% per year.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.16 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.50b (up 7.7% from 3Q 2020). Net income: CN¥268.0m (up 48% from 3Q 2020). Profit margin: 18% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.13 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.34b (up 19% from 2Q 2020). Net income: CN¥224.2m (up 55% from 2Q 2020). Profit margin: 17% (up from 13% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 30Full year 2020 earnings released: EPS CN¥0.69 (vs CN¥1.19 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.23b (down 20% from FY 2019). Net income: CN¥788.2m (down 43% from FY 2019). Profit margin: 15% (down from 21% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Mar 12Full year 2020 earnings released: EPS CN¥0.68 (vs CN¥1.19 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.22b (down 20% from FY 2019). Net income: CN¥785.3m (down 43% from FY 2019). Profit margin: 15% (down from 21% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings.
Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 9.6%. Over the next year, revenue is forecast to grow 35%, compared to a 52% growth forecast for the Chemicals industry in China.
Is New 90 Day High Low • Feb 02New 90-day high: CN¥10.98The company is up 18% from its price of CN¥9.29 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.48 per share.
Is New 90 Day High Low • Nov 23New 90-day high: CN¥10.38The company is up 5.0% from its price of CN¥9.87 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥16.48 per share.
Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥849.2m, down 38% from the prior year. Total revenue was CN¥5.06b over the last 12 months, down 22% from the prior year.
Is New 90 Day High Low • Oct 31New 90-day low: CN¥8.95The company is down 6.0% from its price of CN¥9.56 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.96 per share.